Navigation Links
Dr. Brian Mehling Talks Stem Cells at China's Taishan Academic Forum
Date:11/26/2013

NEW YORK, Nov. 26, 2013 /PRNewswire/ -- Dr. Brian Mehling, New York-based orthopedic surgeon and founder of Blue Horizon International, spoke Sunday in Shangdong, China at the 2013 Taishan Academic Forum International Conference on Hematopoietic Stem Cells and Leukemia.

Over 200 Chinese doctors and graduate students also attended the Taishan Academic Forum 2013 International Conference, sponsored by the Weifang Medical University in Shangdong.  They discussed the use of stem cell treatments for chronic conditions and acute diseases, and how such treatments have changed the face of global health care, allopathic medicines and traditional Chinese medicines.

"Stem cell treatments are without a doubt the future of medicine," stated Dr. Mehling.  "It is very important that young doctors learn about the possibilities in stem cell research, and also about the treatments that are already available for patients with different chronic conditions.

Blue Horizon International is a health care consulting company which combines cutting edge medical treatment and research with philanthropy.  BHI provides resources and services to children and adults of all backgrounds, but especially those who are medically underserved.  BHI subsidiaries have successfully performed over 2000 documented stem cell procedures on over 500 patients to date.  For more information please visit Blue Horizon International at www.bluehorizoninternational.com.

Media Contact:
Odd Einer
+1-212-206-0902

PRLog ID: www.prlog.org/12247276


'/>"/>
SOURCE Blue Horizon International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing
4. Brian Cousins Joins Opedix Joint Support Athletic Wear as Vice President of Business Development
5. Shark Branding Corp. CEO Daymond John and Fuse Science CEO Brian Tuffin to be interviewed on Bloomberg Televisions "Taking Stock with Pimm Fox"
6. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
7. Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, and Implications, a New and Upcoming Drug Safety Webinar Hosted by Xtalks
8. Respiratory Update: Interpreting Minimal Clinically Important Differences in COPD and Demonstrating Product Value with PROs, a New Life Science webinar Hosted by Xtalks
9. Pharmacovigilance: ADR Management and Reporting & Outsourcing Trends, A New Drug Safety Webinar from Xtalks
10. Data-driven Site Negotiations: Fast Track to Fair Market Value (FMV), a New Clinical Trials Webinar from Xtalks
11. Market Access and Pipeline Development – How Healthcare Modeling Can Make a Difference, a Pharmaceutical Market Strategy Webinar from Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)...   BioInformant announces the February 2016 release ... Opportunities, Tools, and Technologies – Market Size, Segments, Trends, ... The first and only market ... BioInformant has more than a decade of historical information ... stem cell type. This powerful 175 page global strategic ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... cell treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols ... patients from around the world. , The new GSCG clinic is headed ...
(Date:2/10/2016)... Feb. 10, 2016  The Maryland House of Delegates ... announced that University of Maryland School of Medicine Dean ... University of Maryland Medical System President and CEO ... Medallion," the highest honor given to the public by ... Dean Reece and Mr. Chrencik for their ...
(Date:2/10/2016)... New York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it ... and develop new vaccines and immunotherapies for infectious diseases and cancer. ...
Breaking Biology Technology:
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first ... (AHA) announced plans to develop a first of its ... power of IBM Watson. In the first application of ... IBM (NYSE: IBM ), and Welltok will create ... health assessments with cognitive analytics, delivered on Welltok,s health ...
(Date:1/25/2016)... 25, 2016  Glencoe Software, the world-leading supplier of ... industries, will provide the data management solution OMERO Plus ... Photo - ... Phenotypic analysis measures the characteristics and ... comparisons between states such as health and disease, the ...
(Date:1/20/2016)... 20, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce the attainment ... are the result of the company,s laser focus on ... , it,s comprehensive, easy-to-use and highly affordable cloud-based ... Key MedNet growth achievements in 2015 include: ...
Breaking Biology News(10 mins):